Table 2.
Baseline mean (SD) (n=150)* | 2 years’ mean (SD) (n=136) | 5 years’ mean (SD) (n=150)* | Change over 5 years’ mean (SD) | P value† | ||
BME lesions (scores) | ||||||
Mean SPARCC score‡ (0–72) | 3.8 (7.2) | 2.8 (5.8) | 2.4 (4.7) | −1.4 (6.5) | 0.009 | |
Structural lesions (scores) | ||||||
Mean number of erosions‡ (0–40) | 1.0 (1.9) | 1.1 (2.0) | 1.2 (2.1) | 0.2 (1.4) | 0.085 | |
Mean number of fatty lesions‡ (0–40) |
1.1 (2.6) | 1.7 (4.0) | 1.9 (4.1) | 0.8 (2.2) | <0.001 | |
Mean number of fatty lesions and/or erosions‡ (0–80) |
2.1 (3.9) | 2.8 (5.0) | 3.1 (5.1) | 1.0 (2.6) | <0.001 | |
Mean total number of lesions‡§ (0–144) |
2.6 (4.5) | 3.3 (6.2) | 3.9 (6.5) | 1.3 (3.1) | <0.001 |
Baseline n (%) (n=150)* |
2 years n (%) (n=136) |
5 years n (%) (n=150)* |
Positive change over 5 years n (%) |
Negative change over 5 years n (%) |
Net change n (%) |
|
BME lesions (cut-off) | ||||||
ASAS definition* | 44 (29.3) | 30 (22.1) | 32 (22.0) | 10 (6.7) | 21 (14.0) | −11 (−7.3) |
Baseline n (%) |
2 years n (%) (n=136) |
5 years n (%) |
Positive change over 5 years n (%) |
Negative change over 5 years n (%) |
Net change n (%) |
|
Structural lesions (cut-offs) | ||||||
≥3 erosions¶ | 20 (13.3) | 21 (15.4) | 21 (13.9) | 8 (5.3) | 7 (4.6) | 1 (0.7) |
≥3 fatty lesions¶ | 20 (13.3) | 26 (19.1) | 32 (21.2) | 12 (8.0) | 0 (0.0) | 12 (8.0) |
≥5 fatty lesions and/or erosions¶ | 23 (15.2) | 32 (23.5) | 33 (21.9) | 12 (8.0) | 2 (1.3) | 10 (6.6) |
*Missing MRI short tau inversion recovery sequence in one case at 5 years.
†Paired samples t-test comparing baseline versus 5 years.
‡Mean of three readers.
§Fatty lesions, erosions, sclerosis and partial ankylosis/total ankylosis.
¶Agreement of ≥2 out of 3 readers.
ASAS, Assessment of Spondyloarthritis International Society; BME, bone marrow oedema; SPARCC, Spondyloarthritis Research Consortium of Canada.